Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2080331Generated: October 28, 2026

1,1-dimethylethyl (2S)-4-{[5'-(aminomethyl)-2'-fluoro-3-biphenylyl]methyl}-2-methyl-1-piperazinecarboxylate → N-[(6-fluoro-3'-{[(3S)-3-methyl-1-piperazinyl]methyl}-3-biphenylyl)methyl]-3-(4-piperidinyl)benzamide

https://huagongshe.com/reaction/2080331

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1,1-dimethylethyl (2S)-4-{[5'-(aminomethyl)-2'-fluoro-3-biphenylyl]methyl}-2-methyl-1-piperazinecarboxylateHCID 25132516—
Reactant3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acidHCID 45073791—
ProductN-[(6-fluoro-3'-{[(3S)-3-methyl-1-piperazinyl]methyl}-3-biphenylyl)methyl]-3-(4-piperidinyl)benzamideHCID 1170602118%

Reaction Steps

Following the standard procedure outlined in Example 57, 1,1-dimethylethyl (2S)-4-{[5′-(aminomethyl)-2′-fluoro-3-biphenylyl]methyl}-2-methyl-1-piperazinecarboxylate, 50 mg, 0.121 mmol) was reacted with the commercially available 3-(1-{[(1,1-dimethylethyl)oxy]carbonyl}-4-piperidinyl)benzoic acid (37 mg, 0.121 mmol) to give the title compound (11 mg, 18%). LC/MS: m/z, 501 (M+H), 1.27 min.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07932247B2
Source datasetuspto-grants-2011_04
ORD IDord-569109b5d30d485d9dbfb859e3d7db9e
Source noteuspto-grants-2011_04